The Lecture Hall

Let's Learn About CRC
Introduction
Metastatic colorectal cancer: Dr. Kasi
Treatment updates 2020: Patient perspective with Dr. Manju George
Biomarkers and CRC: An introduction
Treating metastatic CRC with radiotherapy: Dr. Sanford
The role of precision medicine in the treatment of CRC: Dr. Bekaii-Saab
CtDNA Testing For CRC
New treatment strategies for MSS CRC: Dr. Parikh
Circulating tumor DNA: a new frontier in colorectal cancer: Dr. Cohen
Minimal residual disease in colorectal cancer — Update after ASCO-GI 22: Dr. Kopetz
CtDNA screening tests and the CIRCULATE-US trial: Dr. Lieu
CtDNA testing for patients undergoing liver resection: Dr. Newhook
CtDNA DYNAMIC II clinical trial: Dr. Tie
Immunotherapy
What is immunotherapy?
CRC and immunotherapy: Dr. Keenan
Antibody drug conjugates in CRC: Dr. Raghav
Immunotherapy in MSS Colorectal Cancer: Dr. Fakih
The TIL trial for metastatic CRC: Drs. Lou and Starr
CAMILLA trial — Cabo + Durva for metastatic refractory MSS CRC: Dr. Saeed
Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek
Clinical Trials
Clinical trials resources
Clinical trials demystified, part 1: Adrian Terek
Clinical trials demystified, part 2: Dr. Kurzrock
How to search clinicaltrials.gov
CRC trials in Canada: Dr. Loree
Clinical trials and second opinions at MD Anderson
Lessons from precision medicine and early phase trials: Dr. Kurzrock
PACES trial: Dr. Zell
ERASur trial: Local treatment options for limited stage IV CRC
BREAKWATER trial: Dr. Kopetz
Clinical trials and advanced cancer care at NIH: Dr. Klemen
Phase I trials: Dr. Sharma
TIL trial: Dr. Klemen
BRAF Talks
About BRAF
BRAF V600E research update: Dr. Corcoran (2020)
Overview of BRAF treatment options: Dr. Kopetz (2020)
Targeted therapies and immunotherapy: Dr. Morris (2020)
Tackling targeted therapy refractory BRAF V600E mCRC: Dr. Kopetz (2021)
HERKULES-3 trial for BRAF and RAS: Dr. Lee (2021)
BRAF-mutated CRC updates: Dr. Corcoran (2022)
RAS Talks
KRAS therapies for CRC: Dr. Kopetz
Targeting RAS mutations in CRC: Dr. Lenz
HER2/ERBB2 Talks
HER2 as an emerging target for metastatic CRC patients: Dr. Strickler
All Things Liver
Intro: Liver mets
Advanced surgical treatments for CRC liver mets: Dr. Hernandez-Alejandro
Transplant patients are in the house!
SIRT Y-90 for liver mets
Hepatic Artery Infusion (HAI) chemotherapy for CRC liver mets: Dr. Gholami
Modern-day management of liver metastases: Dr. Soares
Why liver transplant for mCRC is taking off: Dr. Hernandez-Alejandro
Paths to long-term survival with CRC liver mets: Dr. Hernandez-Alejandro
How ablation can be a cancer terminator for liver and lung mets: Dr. Arellano
HAI pump trial: Drs. Cercek, D’Angelica, Lidsky and Maithel
Interview with an icon: Dr. Kemeny on HAI pumps
LUNG METASTASES
Lung surgery for colorectal cancer metastasis: Dr. Atay
Peritoneal Metastases
Peritoneal metastases: Drs. Klempner, Sgarbura, Gongura, & Hübner
Krukenberg tumors and mets to female reproductive organs: Drs. Xie & Sood
The Conference Center: Research Roundups
What are poster walks?
ASCO 2021 Poster Walks
Colorectal cancer conference roundup 2022: Dr. Krishnamurthi & Dr. Eng
CRC updates from GI23: Drs. Eng, Saeed, Smith & Sanford
CRC updates from ASCO 23: Drs. Smith, Krishnamurthi & Sanford
Rectal Cancer
Demystifying radiotherapy in rectal cancer: Dr. Sanford
Radiation in rectal cancer: Dr. VanderWalde
Watch and wait for localized rectal cancer: Dr. Chakrabarti
Update from ASCO 2021
Sexual health after treatment: Dr. Bober
The evolving role of proton therapy for rectal cancer patients: Dr. Jethwa
Non-operative management of rectal cancer: Dr. Kim
Non-operative management of rectal cancer: Dr. Smith
Updates in the treatment of locally advanced rectal cancer: Dr. Ciombor
Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek
PROSPECT trial: Dr. Schrag
Risk of local regrowth after watch and wait in rectal cancer: Dr. Perez
Anal Cancer
Anal cancer developments in 2022: Dr. Eng
Practical Considerations
Prognostication or prophecy: Dr. Briscoe
End-of-life doulas: Amy Bishop
Second opinions: Dr. Lidsky
PTA Resource Fair: Programs & services for kids whose parent has or had cancer
Resource Fair: Mental wellness
Questions? Feedback?
Contact us
Donate
Previous Topic
Next Topic

The evolving role of proton therapy for rectal cancer patients: Dr. Jethwa

The Lecture Hall The evolving role of proton therapy for rectal cancer patients: Dr. Jethwa
Doc Talks

Dr. Krishan Jethwa of Yale discusses proton therapy in this DocTalk, recorded in July, 2021.

Previous Topic
Back to Learning Center
Next Topic